CME Group Inc. · NASDAQ:CME
CME — Cbot Holdings — Merger or Acquisition (March 2007)
38 slides from CME's merger presentation, Mar 23, 2007
Slide 1: CBOT/CME: A Superior Combination for Shareholders, Members and Customers
CBOT/CME: A Superior Combination for Shareholders, Members and Customers CBOT Member/Shareholder Meeting March 22, 2007
Slide 2: Discussion of Forward-Looking Statements
Discussion of Forward-Looking Statements Forward-Looking Statements This presentation may contain forward-looking information regarding Chicago Mercantile Exchange Holdings Inc. and CBOT Holdings, Inc. and the combined company after the completion of the merger that are intended to be covered by the
Slide 3: Terry Duffy, Executive Chairman, CME
Terry Duffy Executive Chairman, CME
Slide 4: A Shared History and Vision for the Future
A Shared History … and Vision for the Future 1848: CBOT founded – derivatives industry is born 1865: CBOT launches first grain futures 1898: Chicago Butter and Egg Board founded 1919: CME established 1972: Financial futures invented 1977: U.S. Treasury futures launched 1981: CME Eurodollar contract
Slide 5: Strategic Benefits of CME's Proposal
Strategic Benefits of CME ’ s Proposal Craig S. Donohue CME Chief Executive Officer
Slide 6: CBOT/CME: Better Together - Our View
Strategically Financially Operationally CBOT/CME: Better Together - Our View ICE’s proposal exaggerates the estimated synergies offers CBOT shareholders a weaker currency will limit CBOT’s comparative future growth potential and value creation opportunities poses significant execution and integratio
Slide 7: We remain confident that our merger will close mid-year 2007
We remain confident that our merger will close mid-year 2007 CBOT/CME DOJ Review On Track • ICE’s comments are misleading • We are well advised by anti-trust counsel and leading economists • We compete in a global market: Domestic and foreign exchanges Securities, options and futures exchanges Cash
Slide 8: ICE's proposed structure/transaction is not a differentiating factor
ICE’s proposed structure/transaction is not a differentiating factor CBOT/CBOE Exercise Right • ICE has proposed same exact structure • ICE has not offered a specific alternative • ICE has not offered CBOT shareholders a guarantee • CBOE has not consented to ICE’s proposal • CME will consider an alt
Slide 9: Better Together - Our View
Operationally Strategically Financially Operationally Better Together – Our View
Slide 10: CBOT/CME is Financially Compelling
CBOT/CME is Financially Compelling • CME and CBOT are 1 st and 3 rd largest exchanges ICE is 10th • CBOT and CME are the most well diversified exchanges in the world - by volume and revenue • ICE has a narrow energy product set • CME offers stronger currency • CME will deliver on synergies
Slide 11: ICE volume and revenue are limited to energy and soft commodity markets
ICE volume and revenue are limited to the energy and soft commodity markets CME Q406 ADV Interest Rates 56% Equity Mini 30% Equity Standard 3% FX 10% Commodities & Alt Investments 1% ICE/NYBOT Q406 ADV Energy 87% Soft Commodities 13% CME Q406 Clearing & Transaction Revenue Interest Rates 44% Equity
Slide 12: CBOT/CME Product/Revenue Diversity
Foreign Exchange 10% Eurodollars 29% Equities 27% Commodity & Other 8% 30-Year Bonds 5% 10-Year Notes 12% 5-Year Notes 5% 2-Year Notes 2% Other Interest Rates 2% Equities 39% Eurodollars 44% Commodities & Other 2% Foreign Exchange 15% CBOT/CME Product/Revenue Diversity Strong and broad platform with
Slide 13: We Operate in a Global Marketplace
CME is the largest global derivatives exchange and has a strong partnership with the leading energy exchange, while ICE/NYBOT is not the largest in any segment Sources: Company press releases and SEC filings We Operate in a Global Marketplace 1,000 2,000 3,000 4,000 5,000 6,000 5,313 3,269 4,628 2,0
Slide 14: CME offers extremely liquid FX markets
CME offers extremely liquid FX markets – FX is CME’s third largest product and is currently averaging the same amount of volume as all ICE futures and all NYBOT combined Monthly Average Daily Volume Total ICE Futures & NYBOT (contracts in thousands) CME FX Volume Equals ICE/NYBOT Total Volume, and S
Slide 15: WTI Average Daily Volume
WTI Average Daily Volume NYMEX on CME Globex vs. ICE CME Successfully Integrates NYMEX, and Takes Market Share Back from ICE (by month; notionally adjusted; contracts in thousands) JUN JUL AUG SEP OCT NOV DEC JAN NYMEX WTI on CME Globex ICE WTI The Electronic Trading Comparison FEB MAR To date Sourc
Slide 16: ICE's unseasoned stock declined 20%
In a challenging market, ICE’s unseasoned stock declined 20% Indexed Price Performance Quality of Currency Characteristics • ICE’s volatility is 30% higher than CME’s • Since ICE’s IPO, ICE’s P/E has fluctuated more than 26 points vs. CME’s fluctuation of 10 points over the same time period • ICE ha
Slide 17: CBOT/CME is Financially Compelling
CBOT/CME is Financially Compelling • CBOT/CME will deliver synergies as promised $125+ million in estimated annual cost savings expected to be achieved year two post closing • CBOT/CME expected to be accretive to GAAP earnings 12 – 18 months post close Cash accretive immediately v. 18 months out w/
Slide 18: ICE claims exaggerated synergies of $240M
ICE claims exaggerated synergies of $240M • We believe that ICE synergies are actually in the $60 – $105M range • If ICE’s synergies are not achieved, the implied value of the ICE currency offered to CBOT shareholders would be less than the offer price CBOT/CME is Financially Compelling
Slide 19: ICE claims exaggerated synergies of $240M
ICE claims exaggerated synergies of $240M CBOT/CME is Financially Compelling • $100M operational expense synergies are questionable Limited insight as to how synergies would be achieved 43% in expense reduction excluding d&a is well outside range of precedents CME view of ICE expense synergies: $40M
Slide 20: CBOT/CME is Strategically Attractive
• CBOT/CME solidifies combined company’s status as the premier global exchange: Broadest product line Deepest liquidity • CBOT/CME builds on 200+ years of innovation • CBOT/CME delivers operational, cost efficiencies • CBOT/CME creates immediate scale advantages • CBOT/CME strengthens Chicago as lea
Slide 21: CBOT/CME better positioned for OTC growth opportunities
CBOT/CME better positioned to take advantage of OTC growth opportunities $0 $45,000 $90,000 $135,000 $180,000 $225,000 $270,000 Interest Rates FX Credit Default Equity-linked Commodity CBOT/CME is Strategically Attractive Source: June 2006 Notional Value Outstanding per March 2007 BIS Quarterly Revi
Slide 22: CBOT/CME: The Superior Combination
CBOT/CME: The Superior Combination Most significant opportunities for growth Best ability to execute and integrate ICE CME Broadest global distribution Most scalable technology Industry-leading clearing house Ability to deliver promised synergies Most robust product line Greatest operational efficie
Slide 23: The CBOT/CME Clearing Advantage
The CBOT/CME Clearing Advantage Kim Taylor President, CME Clearing
Slide 24: Benefits of the Common Clearing Link
Benefits of the Common Clearing Link • Offers rock solid operational reliability • Provides high degree of risk management and financial integrity • Delivers low-cost services • Leverages scalability and adaptability
Slide 25: ICE lacks operational capacity to clear business of CBOT's magnitude
ICE lacks operational capacity to clear business of CBOT’s magnitude Clearing: Operational Benefits • NYBOT would need to scale up clearing capacity to accommodate CBOT volume: By 18+ times to accommodate CBOT ADV on day one By 30 times to handle peak volume • CME has supported give-up functionality
Slide 26: ICE's net margining proposal is a step backwards
ICE’s net margining proposal is a step backwards Clearing: Risk Management & Financial Integrity • CME offers important innovation over clearing houses that offer solely net or gross margining: CBOT house portfolios are margined net by CME CBOT customer portfolios have the choice between net margini
Slide 27: ICE cross-margining efficiencies don't compare to CME/CBOT
ICE cross-margining efficiencies of $50 million don’t compare to margin efficiencies with CME/CBOT Clearing: Cost & Capital Efficiencies • The combination of CME & CBOT products under a single clearing house resulted in significant capital savings & efficiency for the market Potential Margin Efficie
Slide 28: Five of the top CBOT volume firms are not NYBOT clearing members
Five of the top 10 CBOT volume firms are not NYBOT clearing members Clearing: Growth Capabilities • CME Clearing already has a strong foundation to continue growing the combined business of the CME & CBOT • Clearing provides the following capabilities to support or drive growth in our combined busin
Slide 29: Leveraging Operational Excellence for Customers
Leveraging Operational Excellence for Customers Phupinder Gill Chief Operating Officer
Slide 30: CME/CBOT Leverages Operational Excellence
CME/CBOT Leverages Operational Excellence • Clearing • Technology • Ready to execute
Slide 31: Technology Investment Fuels Growth
To support scaling of technology infrastructure, CME has averaged $70M for past 5 years in capital reinvestment, while ICE/NYBOT combined have averaged less than $20M Source: CME 2006 and 2003 10Ks, CME press release dated 1/30/07, ICE 8K filed 3/13/07, ICE 2006 10K, ICE S1 filed 3/22/05, and ICE pr
Slide 32: CME Globex: High Volume, High Speed
While orders/transactions grew by a factor of 30, the average round trip time fell 80% from its 2004 level CME Globex: High Volume, High Speed Monthly Total Order Volume vs. Avg. RTT 200,000,000 400,000,000 600,000,000 800,000,000 1,000,000,000 1,200,000,000 0.00 20.00 40.00 60.00 80.00 100.00 120.0
Slide 33: ICE charges customers more than twice the CME and CBOT rate per contract
ICE charges customers, on average, more than twice the CME and CBOT rate per contract CBOT/CME is Financially Compelling • ICE operating margins are the highest of any U.S. exchange, near 70% • Existing ICE clearing costs are 9¢ per side vs. CBOT clearing charge of 6¢ per side • ICE rate per contrac
Slide 34: Customers Win with CBOT/CME
Customers Win with CBOT/CME • Retention of common clearing link efficiencies CBOT/CME retains more than $1 billion in margining efficiencies v. ICE/CBOT $50M • Lower costs for end users and firms At least $70M in annual savings – trading floor unification and Globex ICE transaction requires interfac
Slide 35: Customers trade more when they save more
Customers trade more when they save more. Calling Them on the (Red) Carpet ICE claims they will see overwhelming support from the FCM community, from FIA and from Wall Street • We have to ask, why would these constituents who cheered the common clearing link: Give back more than $1 billion in margin
Slide 36: Questions & Answers
Questions & Answers CBOT Member/Shareholder Meeting March 22,
Slide 37: CBOT/CME: Better Together - Our View
Strategically Financially Operationally CBOT/CME: Better Together - Our View ICE’s proposal exaggerates the estimated synergies offers CBOT shareholders a weaker currency will limit CBOT’s comparative future growth potential and value creation opportunities poses significant execution and integratio
Slide 38: CBOT/CME: A Superior Combination for Shareholders, Members and Customers
CBOT/CME: A Superior Combination for Shareholders, Members and Customers CBOT Member/Shareholder Meeting March 22, 2007